Faes Farma, S.A. (BME:FAE)

Spain flag Spain · Delayed Price · Currency is EUR
5.20
+0.33 (6.78%)
At close: Feb 27, 2026
42.08%
Market Cap 1.62B
Revenue (ttm) 571.12M
Net Income (ttm) 105.08M
Shares Out 311.26M
EPS (ttm) 0.34
PE Ratio 15.42
Forward PE 17.05
Dividend 0.16 (3.22%)
Ex-Dividend Date Jan 8, 2026
Volume 358,211
Average Volume 160,263
Open 4.89
Previous Close 4.87
Day's Range 4.89 - 5.20
52-Week Range 3.27 - 5.44
Beta 0.25
RSI 52.74
Earnings Date Feb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec... [Read more]

Sector Healthcare
Founded 1933
Employees 1,894
Stock Exchange Madrid Stock Exchange
Ticker Symbol FAE
Full Company Profile

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial Statements

News

There is no news available yet.